ES2062065T3 - Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente. - Google Patents
Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente.Info
- Publication number
- ES2062065T3 ES2062065T3 ES89401979T ES89401979T ES2062065T3 ES 2062065 T3 ES2062065 T3 ES 2062065T3 ES 89401979 T ES89401979 T ES 89401979T ES 89401979 T ES89401979 T ES 89401979T ES 2062065 T3 ES2062065 T3 ES 2062065T3
- Authority
- ES
- Spain
- Prior art keywords
- prevention
- sexually
- pharmaceutical composition
- diseases
- communicable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA COMPOSICION FARMACEUTICA PARA LA PREVENCION DE ENFERMEDADES TRANSMISIBLES SEXUALMENTE SEGUN LA INVENCION ESTA DESTINADA A SER PUESTA EN CONTACTO CON UNA MUCOSA. ESTA CARACTERIZADA PORQUE CONTIENE, POR UNA PARTE, POR LO MENOS UN PRINCIPIO ACTIVO CONTRA VIRUS Y BACTERIAS RESPONSABLES DE DICHAS ENFERMEDADES TRANSMISIBLES SEXUALMENTE Y, POR OTRA PARTE, UN PRODUCTO INHIBIDOR DE PENETRACION DE DICHO PRINCIPIO ACTIVO A TRAVES DE UNA MUCOSA, EN COMBINACION CON UN VEHICULO FARMACEUTICAMENTE ACEPTABLE, ADAPTADO PARA UNA ADMINISTRACION POR VIA TOPICA DE ESTA COMPOSICION. PREFERIBLEMENTE, EL PRODUCTO INHIBIDOR DE PENETRACION ES UN FILMOGENO, APTO PARA FORMAR UNA PELICULA A LA QUE ESTAN ASOCIADOS EL O LOS PRINCIPIOS ACTIVOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8809418 | 1988-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2062065T3 true ES2062065T3 (es) | 1994-12-16 |
Family
ID=9368330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89401979T Expired - Lifetime ES2062065T3 (es) | 1988-07-11 | 1989-07-10 | Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente. |
Country Status (38)
Country | Link |
---|---|
US (1) | US5439685A (es) |
EP (1) | EP0351301B1 (es) |
JP (1) | JPH0774164B2 (es) |
KR (1) | KR0143231B1 (es) |
CN (1) | CN1035038C (es) |
AP (1) | AP108A (es) |
AR (1) | AR243381A1 (es) |
AT (1) | ATE97570T1 (es) |
BR (1) | BR8903523A (es) |
CA (1) | CA1341304C (es) |
CZ (1) | CZ280722B6 (es) |
DD (1) | DD283932A5 (es) |
DE (1) | DE68910892T2 (es) |
DK (1) | DK173527B1 (es) |
ES (1) | ES2062065T3 (es) |
FI (1) | FI101595B1 (es) |
HK (1) | HK131095A (es) |
HU (1) | HU206634B (es) |
IE (1) | IE63115B1 (es) |
IL (1) | IL90910A (es) |
LT (1) | LT3754B (es) |
LV (1) | LV10573B (es) |
MA (1) | MA22036A1 (es) |
MD (1) | MD406C2 (es) |
MX (1) | MX170801B (es) |
MY (1) | MY106242A (es) |
NO (1) | NO178843C (es) |
NZ (1) | NZ229891A (es) |
OA (1) | OA09123A (es) |
PL (1) | PL161848B1 (es) |
PT (1) | PT91108B (es) |
RU (1) | RU2065742C1 (es) |
SK (1) | SK278614B6 (es) |
TN (1) | TNSN89074A1 (es) |
TR (1) | TR28353A (es) |
UA (1) | UA26124A (es) |
YU (1) | YU47899B (es) |
ZA (1) | ZA895263B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02258718A (ja) * | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
US5693769A (en) * | 1991-12-13 | 1997-12-02 | Transcell Technologies, Inc. | Glycosylated steroid derivatives for transport across biological membranes and process for making and using same |
US5795870A (en) * | 1991-12-13 | 1998-08-18 | Trustees Of Princeton University | Compositions and methods for cell transformation |
IT1255450B (it) * | 1992-06-30 | 1995-10-31 | Montefarmaco Spa | Uso di acidi biliari come agenti antivirali |
AU688344B2 (en) * | 1993-07-19 | 1998-03-12 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Hepatitis C virus proliferation inhibitor |
DE4341139C1 (de) * | 1993-12-02 | 1995-04-13 | Upmeyer Hans Juergen | Dimeticon zur Behandlung von Aphthen |
US5667492A (en) * | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
US5700679A (en) * | 1996-06-07 | 1997-12-23 | Novavax, Inc. | Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity |
GB2318292A (en) * | 1996-09-12 | 1998-04-22 | Simon Everard Barton | Saliva-like protectants |
US6211243B1 (en) | 1999-09-22 | 2001-04-03 | B. Ron Johnson | Methods for treating cold sores with anti-infective compositions |
US8173709B2 (en) * | 1999-09-22 | 2012-05-08 | Quadex Pharmaceuticals, Llc | Anti-infective methods for treating pathogen-induced disordered tissues |
US6759434B2 (en) | 1999-09-22 | 2004-07-06 | B. Ron Johnson | Anti-infective compositions, methods and systems for treating disordered tissue |
US20050232868A1 (en) * | 1999-10-19 | 2005-10-20 | The Procter & Gamble Company | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
AU2001243431B2 (en) * | 2000-03-07 | 2006-05-25 | Rush University Medical Center | Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
US8093446B2 (en) * | 2001-04-11 | 2012-01-10 | Playtex Products, Inc. | Fibrous absorbent articles having malodor counteractant |
GB2415626B (en) * | 2001-04-11 | 2006-03-08 | Playtex Products Inc | Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor |
GB2412121B (en) * | 2001-04-11 | 2006-01-11 | Playtex Products Inc | Tampon with malodour counteractant |
ES2237732T3 (es) * | 2003-11-03 | 2005-08-01 | Peter-Hansen Volkmann | Composicion para el cuidado vaginal. |
WO2007027636A2 (en) * | 2005-08-29 | 2007-03-08 | Sepsicure L.L.C. | Method for treatment or prevention of conditions caused by gram-positive bacteria |
DE102006020644A1 (de) * | 2006-04-28 | 2007-10-31 | Bayer Innovation Gmbh | Antiseptikahaltige Silikonelastomere |
US8409557B2 (en) | 2006-09-28 | 2013-04-02 | Clji Ip Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
US8062631B2 (en) | 2006-09-28 | 2011-11-22 | Clji I.P. Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
AU2012203566B1 (en) * | 2008-03-27 | 2013-09-12 | Clji I.P. Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
KR101130754B1 (ko) | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
RU2591786C2 (ru) | 2010-11-12 | 2016-07-20 | Дзе Юниверсити Оф Юта Рисерч Фаундейшн | Интравагинальные устройства для контролируемой доставки лубрикантов |
CA2832854C (en) | 2011-04-19 | 2020-04-28 | Afif GHANNOUM | Method of inhibiting harmful microorganisms and barrier-forming composition therefor |
US10426761B2 (en) | 2011-04-19 | 2019-10-01 | Arms Pharmaceutical, Llc | Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof |
CA2781379C (en) | 2012-03-26 | 2013-09-03 | Clji Ip Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
US9463180B2 (en) | 2013-03-14 | 2016-10-11 | Quadex Pharmaceuticals, Llc | Treatment of molluscum contagiosum |
US9549930B2 (en) | 2013-03-14 | 2017-01-24 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered and/or prodromal stage tissue |
US9125911B2 (en) | 2013-03-14 | 2015-09-08 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered tissues |
KR102399883B1 (ko) * | 2021-02-09 | 2022-05-20 | 재단법인대구경북과학기술원 | 압출용 복합고분자 펠릿 및 이의 제조방법 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1161484A (en) * | 1965-08-20 | 1969-08-13 | Mediline Ag | Toilet Preparation |
SE353658B (es) * | 1967-06-13 | 1973-02-12 | Dow Corning | |
US3710795A (en) * | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
US3770648A (en) * | 1971-07-12 | 1973-11-06 | Bristol Myers Co | Anhydrous aerosol foam |
BE791632A (fr) * | 1971-11-20 | 1973-05-21 | Schering Ag | Supports a base de caoutchouc siliconique pour agents medicamenteux |
US4393871A (en) * | 1977-06-27 | 1983-07-19 | Vli Corporation | Vaginal device |
US4228797A (en) * | 1978-09-25 | 1980-10-21 | Dickey Richard P | Intravaginal contraception method |
ZA827582B (en) * | 1981-11-06 | 1983-08-31 | Ansell Inc | Spermicidal condom |
ZA828965B (en) * | 1981-12-07 | 1984-07-25 | Syntex Inc | Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles |
DE3204124A1 (de) * | 1982-02-06 | 1983-08-18 | Bayer Ag, 5090 Leverkusen | Antimykotische tampons mit hoher wirkstoff-freisetzung |
AU2272883A (en) * | 1982-12-22 | 1984-06-28 | Herpes Pharmaceutical Inc. | Pharmaceutical compositions of steriods for treatment of herpes simplex infections |
DE3346641A1 (de) * | 1983-12-23 | 1985-07-04 | Dynamit Nobel Ag, 5210 Troisdorf | Silanmodifizierte estergemische |
GB8402748D0 (en) * | 1984-02-02 | 1984-03-07 | Dunlop Ltd | Intravaginal device |
NL8600929A (nl) * | 1986-04-11 | 1987-11-02 | Fundatech Sa | Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium. |
IT1213323B (it) * | 1986-08-07 | 1989-12-20 | Crinos Industria Farmaco | Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida |
US4952411A (en) * | 1987-02-25 | 1990-08-28 | Trustees Of Columbia University In The City Of New York | Method of inhibiting the transmission of AIDS virus |
GB8706313D0 (en) * | 1987-03-17 | 1987-04-23 | Health Lab Service Board | Treatment & prevention of viral infections |
FR2614525B1 (fr) * | 1987-04-29 | 1995-11-10 | Jacques Augros | Tampon en eponge elastique, notamment tampon vaginal |
US4922928A (en) * | 1988-08-17 | 1990-05-08 | Michael Burnhill | Vaginal device |
-
1989
- 1989-07-07 NO NO892826A patent/NO178843C/no unknown
- 1989-07-10 DK DK198903402A patent/DK173527B1/da not_active IP Right Cessation
- 1989-07-10 AR AR89314348A patent/AR243381A1/es active
- 1989-07-10 MA MA21844A patent/MA22036A1/fr unknown
- 1989-07-10 TN TNTNSN89074A patent/TNSN89074A1/fr unknown
- 1989-07-10 PT PT91108A patent/PT91108B/pt not_active IP Right Cessation
- 1989-07-10 IE IE221889A patent/IE63115B1/en not_active IP Right Cessation
- 1989-07-10 YU YU135789A patent/YU47899B/sh unknown
- 1989-07-10 AT AT89401979T patent/ATE97570T1/de not_active IP Right Cessation
- 1989-07-10 FI FI893340A patent/FI101595B1/fi not_active IP Right Cessation
- 1989-07-10 RU SU4614544/14A patent/RU2065742C1/ru not_active IP Right Cessation
- 1989-07-10 ES ES89401979T patent/ES2062065T3/es not_active Expired - Lifetime
- 1989-07-10 CA CA000605271A patent/CA1341304C/fr not_active Expired - Fee Related
- 1989-07-10 UA UA4614544A patent/UA26124A/uk unknown
- 1989-07-10 IL IL9091089A patent/IL90910A/en not_active IP Right Cessation
- 1989-07-10 EP EP89401979A patent/EP0351301B1/fr not_active Expired - Lifetime
- 1989-07-10 MY MYPI89000940A patent/MY106242A/en unknown
- 1989-07-10 DE DE89401979T patent/DE68910892T2/de not_active Expired - Fee Related
- 1989-07-10 MX MX016734A patent/MX170801B/es unknown
- 1989-07-10 HU HU893459A patent/HU206634B/hu not_active IP Right Cessation
- 1989-07-11 JP JP1177278A patent/JPH0774164B2/ja not_active Expired - Fee Related
- 1989-07-11 OA OA59610A patent/OA09123A/xx unknown
- 1989-07-11 TR TR00603/89A patent/TR28353A/xx unknown
- 1989-07-11 SK SK4238-89A patent/SK278614B6/sk unknown
- 1989-07-11 ZA ZA895263A patent/ZA895263B/xx unknown
- 1989-07-11 CZ CS894238A patent/CZ280722B6/cs not_active IP Right Cessation
- 1989-07-11 AP APAP/P/1989/000133A patent/AP108A/en active
- 1989-07-11 BR BR898903523A patent/BR8903523A/pt not_active IP Right Cessation
- 1989-07-11 DD DD89330678A patent/DD283932A5/de not_active IP Right Cessation
- 1989-07-11 CN CN89104829A patent/CN1035038C/zh not_active Expired - Lifetime
- 1989-07-11 KR KR1019890009850A patent/KR0143231B1/ko not_active IP Right Cessation
- 1989-07-11 PL PL89280531A patent/PL161848B1/pl unknown
- 1989-07-11 NZ NZ229891A patent/NZ229891A/xx unknown
-
1992
- 1992-12-22 US US07/995,522 patent/US5439685A/en not_active Expired - Lifetime
-
1993
- 1993-02-25 LV LVP-93-140A patent/LV10573B/en unknown
- 1993-12-22 LT LTIP1660A patent/LT3754B/lt not_active IP Right Cessation
-
1994
- 1994-12-30 MD MD95-0089A patent/MD406C2/ro unknown
-
1995
- 1995-08-17 HK HK131095A patent/HK131095A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2062065T3 (es) | Composicion farmaceutica para la prevencion de enfermedades que son transmisibles sexualmente. | |
AR039130A2 (es) | Metodo de administracion de un agente farmaceuticamente activo a un ojo humano | |
BR9206631A (pt) | Sistema de maior penetração na pele para melhor administração tópica de medicamentos | |
MY100721A (en) | Therapeutic agent. | |
AR038575A1 (es) | Formulacion oftalmica con nueva composicion de goma | |
AR023715A1 (es) | Composicion farmaceutica para un sujeto que necesita una elevacion del contenido de nad intracelular, y el uso de la misma para la manufactura de unmedicamento para aumentar las respuestas celulares protectoras al stress genotoxico en la piel | |
BR9908438A (pt) | Tabletes de desintegração rápida | |
BR9406893A (pt) | Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids | |
HUP9901144A2 (hu) | Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények | |
ES551370A0 (es) | Procedimiento para preparar una dispersion acuosa estable, congelada, de un copolimero y una droga soluble en agua. (como desglose y con prioridad de la patente espanola no. 544.580, presentada el 26 de junio de 1985). | |
AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
KR870005637A (ko) | 약물 데포 | |
ES2088312T3 (es) | Formulacion de liberacion controlada que contiene tramadol. | |
EP0679390A3 (en) | Sprayable topical pharmaceutical compositions | |
BR9607234A (pt) | Grânulos mucoadesivos uso dos mesmos processo para sua preparação composição farmâceutica e uso da mesma | |
BR0014159A (pt) | Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional | |
UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
ES2098920T3 (es) | Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina. | |
MX9710206A (es) | Composicion farmaceutica de amiodarone para administracion parenteral. | |
ES2130081B1 (es) | Comprimido de maleato de trimebutina con recubrimiento laminar. | |
IT1275816B1 (it) | Composizioni farmaceutiche solide per uso vaginale | |
IL100881A0 (en) | Prophylactic devices for destruction of the human immunodeficiency virus during sexual relations | |
AR012868A1 (es) | COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN PÉPTIDO AGONISTA DE LHRH, UN ANTAGONISTA DE LHRH O UN PÉPTIDO DE GRF Y NICOTINAMIDA. | |
CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
WO2003011249A3 (en) | Ophthalmic composition containing n-acetylcysteine for the treat ment of dry-eye syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 351301 Country of ref document: ES |